BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18708400)

  • 21. The genetic association between PON1 polymorphisms and osteonecrosis of femoral head: A case-control study.
    Li JM; Li Y; Wang L
    Medicine (Baltimore); 2017 Oct; 96(42):e8198. PubMed ID: 29049204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraoxonase 1 gene variants concerning cardiovascular mortality in conventional cigarette smokers and non-smokers treated with hemodialysis.
    Grzegorzewska AE; Ostromecka K; Świderska MK; Adamska P; Mostowska A; Jagodziński PP
    Sci Rep; 2021 Sep; 11(1):19467. PubMed ID: 34593900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of the relationship between paraoxonase 1 polymorphisms and cancer.
    Liu P; Wang Q; Cui Y; Wang J
    Free Radic Res; 2019 Dec; 53(11-12):1045-1050. PubMed ID: 31762361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-2 gene and epithelial ovarian carcinoma risk.
    Agachan Cakmakoglu B; Attar R; Kahraman OT; Dalan AB; Iyibozkurt AC; Karateke A; Attar E
    Mol Biol Rep; 2011 Jun; 38(5):3481-6. PubMed ID: 21107726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin gene polymorphism CALCA-624 (T/C) and ovarian cancer.
    Goodman MT; Ferrell R; McDuffie K; Thompson PJ; Wilkens LR; Bushley AW; Tung KH; Carney ME; Ness RB
    Environ Mol Mutagen; 2005 Jul; 46(1):53-8. PubMed ID: 15880427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation of the single nucleotide polymorphism rs662 of PON1 with the risk of male infertility].
    Liu HH; Zhao J; Xu J; Zhu PR; Yu MM; Jiang WJ; Zhang J; Li WW; Wu QY; Li ZR; Xia XY
    Zhonghua Nan Ke Xue; 2018 Aug; 24(8):708-712. PubMed ID: 30173430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of caffeine intake and CYP1A2 genotype with ovarian cancer.
    Goodman MT; Tung KH; McDuffie K; Wilkens LR; Donlon TA
    Nutr Cancer; 2003; 46(1):23-9. PubMed ID: 12925300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: a meta-analysis.
    Saadat M
    Cancer Epidemiol; 2012 Apr; 36(2):e101-3. PubMed ID: 22133529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.
    Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC
    Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Q192R polymorphism of the paraoxonase-1 gene as a risk factor for obesity in Portuguese women.
    Veiga L; Silva-Nunes J; Melão A; Oliveira A; Duarte L; Brito M
    Eur J Endocrinol; 2011 Feb; 164(2):213-8. PubMed ID: 21078685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin E intake and paraoxonase 1 (
    Bui QA; Gunathilake M; Lee J; Oh JH; Chang HJ; Sohn DK; Shin A; Kim J
    Int J Food Sci Nutr; 2023; 74(4):510-521. PubMed ID: 37282563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of PON1 192 and PON1 55 polymorphisms in ovarian cancer patients in Turkish population.
    Arpaci A; Görmüs U; Dalan B; Berkman S; Isbir T
    In Vivo; 2009; 23(3):421-4. PubMed ID: 19454508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraoxonase single nucleotide variants show associations with polycystic ovary syndrome: a meta-analysis.
    Kunjantarachot A; Pabalan N; Jarjanazi H; Christofolini DM; Montagna E; Barbosa CP; Bianco B
    Reprod Biol Endocrinol; 2020 Nov; 18(1):114. PubMed ID: 33218342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes.
    Li Y; Zhang HL; Kang S; Zhou RM; Wang N
    Gynecol Oncol; 2017 Jan; 144(1):140-145. PubMed ID: 27836206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis on relationship between paraoxonase 1 polymorphisms and atherosclerotic cardiovascular diseases.
    Zeng Q; Zeng J
    Life Sci; 2019 Sep; 232():116646. PubMed ID: 31302193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer.
    Bushley AW; Ferrell R; McDuffie K; Terada KY; Carney ME; Thompson PJ; Wilkens LR; Tung KH; Ness RB; Goodman MT
    Gynecol Oncol; 2004 Dec; 95(3):672-9. PubMed ID: 15581980
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Grdić Rajković M; Popović-Grle S; Vukić Dugac A; Rogić D; Rako I; Radić Antolić M; Beriša M; Rumora L
    J Clin Pathol; 2018 Nov; 71(11):963-970. PubMed ID: 29858231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians.
    Agrawal S; Tripathi G; Prajnya R; Sinha N; Gilmour A; Bush L; Mastana S
    Indian J Med Sci; 2009 Aug; 63(8):335-44. PubMed ID: 19770524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.